These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

487 related items for PubMed ID: 26601964

  • 1. Efficacy and Safety of Evacetrapib for Modifying Plasma Lipids: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Sahebkar A, Simental-Mendía LE, Guerrero-Romero F, Golledge J, Watts GF.
    Curr Pharm Des; 2016; 22(5):595-608. PubMed ID: 26601964
    [Abstract] [Full Text] [Related]

  • 2. Effects of the CETP inhibitor evacetrapib administered as monotherapy or in combination with statins on HDL and LDL cholesterol: a randomized controlled trial.
    Nicholls SJ, Brewer HB, Kastelein JJ, Krueger KA, Wang MD, Shao M, Hu B, McErlean E, Nissen SE.
    JAMA; 2011 Nov 16; 306(19):2099-109. PubMed ID: 22089718
    [Abstract] [Full Text] [Related]

  • 3. Efficacy, safety, tolerability, and pharmacokinetic profile of evacetrapib administered as monotherapy or in combination with atorvastatin in Japanese patients with dyslipidemia.
    Teramoto T, Takeuchi M, Morisaki Y, Ruotolo G, Krueger KA.
    Am J Cardiol; 2014 Jun 15; 113(12):2021-9. PubMed ID: 24786356
    [Abstract] [Full Text] [Related]

  • 4. Nigella sativa (black seed) effects on plasma lipid concentrations in humans: A systematic review and meta-analysis of randomized placebo-controlled trials.
    Sahebkar A, Beccuti G, Simental-Mendía LE, Nobili V, Bo S.
    Pharmacol Res; 2016 Apr 15; 106():37-50. PubMed ID: 26875640
    [Abstract] [Full Text] [Related]

  • 5. A PRISMA-compliant systematic review and meta-analysis of randomized controlled trials investigating the effects of statin therapy on plasma lipid concentrations in HIV-infected patients.
    Banach M, Dinca M, Ursoniu S, Serban MC, Howard G, Mikhailidis DP, Nicholls S, Lip GYH, Glasser S, Martin SS, Muntner P, Rysz J, Toth PP, Sahebkar A, Lipid Blood Pressure Meta-analysis Collaboration Group.
    Pharmacol Res; 2016 Sep 15; 111():343-356. PubMed ID: 27350264
    [Abstract] [Full Text] [Related]

  • 6. Evacetrapib and Cardiovascular Outcomes in High-Risk Vascular Disease.
    Lincoff AM, Nicholls SJ, Riesmeyer JS, Barter PJ, Brewer HB, Fox KAA, Gibson CM, Granger C, Menon V, Montalescot G, Rader D, Tall AR, McErlean E, Wolski K, Ruotolo G, Vangerow B, Weerakkody G, Goodman SG, Conde D, McGuire DK, Nicolau JC, Leiva-Pons JL, Pesant Y, Li W, Kandath D, Kouz S, Tahirkheli N, Mason D, Nissen SE, ACCELERATE Investigators.
    N Engl J Med; 2017 May 18; 376(20):1933-1942. PubMed ID: 28514624
    [Abstract] [Full Text] [Related]

  • 7. Impact of ursodeoxycholic acid on circulating lipid concentrations: a systematic review and meta-analysis of randomized placebo-controlled trials.
    Simental-Mendía LE, Simental-Mendía M, Sánchez-García A, Banach M, Serban MC, Cicero AFG, Sahebkar A.
    Lipids Health Dis; 2019 Apr 06; 18(1):88. PubMed ID: 30954082
    [Abstract] [Full Text] [Related]

  • 8. Efficacy and Safety of Cholesteryl Ester Transfer Protein Inhibitor Evacetrapib Administered as Monotherapy in Japanese Patients With Primary Hypercholesterolemia.
    Teramoto T, Kiyosue A, Iimura T, Takita Y, Riesmeyer JS, Murakami M.
    Circ J; 2017 Oct 25; 81(11):1686-1692. PubMed ID: 28652529
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Efficacy and Safety of Mipomersen: A Systematic Review and Meta-Analysis of Randomized Clinical Trials.
    Fogacci F, Ferri N, Toth PP, Ruscica M, Corsini A, Cicero AFG.
    Drugs; 2019 May 25; 79(7):751-766. PubMed ID: 30989634
    [Abstract] [Full Text] [Related]

  • 11. Effects of the cholesteryl ester transfer protein inhibitor evacetrapib on lipoproteins, apolipoproteins and 24-h ambulatory blood pressure in healthy adults.
    Suico JG, Wang MD, Friedrich S, Cannady EA, Konkoy CS, Ruotolo G, Krueger KA.
    J Pharm Pharmacol; 2014 Nov 25; 66(11):1576-85. PubMed ID: 24961753
    [Abstract] [Full Text] [Related]

  • 12. The effects of cinnamon supplementation on blood lipid concentrations: A systematic review and meta-analysis.
    Maierean SM, Serban MC, Sahebkar A, Ursoniu S, Serban A, Penson P, Banach M, Lipid and Blood Pressure Meta-analysis Collaboration (LBPMC) Group.
    J Clin Lipidol; 2017 Nov 25; 11(6):1393-1406. PubMed ID: 28887086
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Efficacy and Safety of the Cholesteryl Ester Transfer Protein Inhibitor Evacetrapib in Combination With Atorvastatin in Japanese Patients With Primary Hypercholesterolemia.
    Teramoto T, Kiyosue A, Iimura T, Takita Y, Riesmeyer JS, Murakami M.
    Circ J; 2017 Dec 25; 82(1):183-191. PubMed ID: 28768921
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. The effects of green coffee bean extract supplementation on lipid profile in humans: A systematic review and meta-analysis of randomized controlled trials.
    Ding F, Ma B, Nazary-Vannani A, Kord-Varkaneh H, Fatahi S, Papageorgiou M, Rahmani J, Poursoleiman F, Júnior Borges do Nascimento I, Li H, Han D, Wang D.
    Nutr Metab Cardiovasc Dis; 2020 Jan 03; 30(1):1-10. PubMed ID: 31748178
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.